$INDV insider trading
Over the last 12 months, Indivior Pharmaceuticals insiders reported 10 buys totaling $312K and 3 sales totaling $2.8M across SEC Form 4 filings. 62% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $312K 10 events
- Sold · 12m
- $2.8M 3 events
- Events · 12m
- 13 Form 4 filings, grouped
- Insiders · 12m
- 9 distinct reporters
- 10b5-1 share
- 62% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Anderson Woodrow DChief Accounting Officer · O | ▲ Buy | 1,500 | $35.69 | $54K | +5.7% | — |
| Aug 5, 2026 | Anderson Woodrow DChief Accounting Officer · O | ▲ Buy | 1,500 | $36.28 | $54K | +6.1% | — |
| Jul 10, 2026 | Heidbreder ChristianChief Scientific Officer · O | ▼ Sale | 18,586 | $41.14 | $765K | -8.2% | plan |
| Jun 11, 2026 | Heidbreder ChristianChief Scientific Officer · O | ▼ Sale | 18,586 | $38.06 | $707K | -7.5% | plan |
| Jun 8, 2026 | Preblick RyanChief Financial Officer · O | ▼ Sale | 36,000 | $37.7 | $1.4M | -11.2% | plan |
| Mar 13, 2026 | Ryan BarbaraD | ▲ Buy | 8 | $31.08 | $249 | +0.1% | — |
| Mar 9, 2026 | Ryan BarbaraD | ▲ Buy | 31 | $32.56 | $1K | +0.5% | — |
| Mar 6, 2026 | Kingsley Stuart AD | ▲ Buy | 940 | $31.86 | $30K | +20.2% | — |
| Jan 5, 2026 | Humphreys KeithD | ▲ Buy | 775 | $35.39 | $27K | +15.4% | plan |
| Jan 5, 2026 | Ryan BarbaraD | ▲ Buy | 775 | $35.39 | $27K | +65.2% | plan |
| Jan 5, 2026 | Wheadon David E.D | ▲ Buy | 1,771 | $35.39 | $63K | +14% | plan |
| Jan 5, 2026 | Stejbach MarkD | ▲ Buy | 775 | $35.39 | $27K | +4.8% | plan |
| Jan 5, 2026 | NINIVAGGI DANIEL AD | ▲ Buy | 775 | $35.39 | $27K | +4.8% | plan |
Every $INDV filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Indivior Pharmaceuticals filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $INDV feed.